Educational Activities

Show Filters
Hide Filters
1-6 of 9 Activities
Title
Availability
Format
Credits
Course Opens
Buttons

2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access

This Rapid Recap will provide a responsive, timely, and incisive overview of data presented at the 2022 Clinical Oncology Annual Meeting, and offer expert insights into the shifting management landscape for metastatic EGFR+ NSCLC.

 

1.00
07/06/2022

Natasha B. Leighl

Thoracic Medical Oncology Group, Princess Margaret Cancer Centre
Professor, Department of Medicine
Adjunct Professor, Institute of Health Policy Management and Evaluation
University of Toronto, Toronto, ON, Canada

Natasha B. Leighl

Thoracic Medical Oncology Group, Princess Margaret Cancer Centre,
Professor, Department of Medicine,
Adjunct Professor, Institute of Health Policy Management and Evaluation,
University of Toronto, Toronto, ON, Canada

Helena Yu

Lung Cancer Medical Oncologist,
Memorial Sloan Kettering Cancer Center,
New York, NY

Helena Yu

Lung Cancer Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY

Jill Feldman

Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL

Jill Feldman

Lung Cancer Patient and Advocate
Chair, IASLC Patient Advocacy Committee
Co-Founder EGFR Resisters
Deerfield Park, IL

Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface Podcast

All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies.

1.0
08/15/2022

Javed Butler, MD, MPH, MBA

President, Baylor Scott and White Research Institute, Dallas, TX
Distinguished Professor of Medicine
University of Mississippi, Jackson, MS

Javed Butler, MD, MPH, MBA

President, Baylor Scott and White Research Institute, Dallas, TX
Distinguished Professor of Medicine
University of Mississippi, Jackson, MS

Matthew R. Weir, MD

Director, Division of Nephrology
Professor of Medicine
University of Maryland Medical System, Baltimore, MD

Matthew R. Weir, MD

Director, Division of Nephrology
Professor of Medicine
University of Maryland Medical System
Baltimore, MD

Harnessing the Power of Immunotherapy in HCC and BTC: An Expert Exploration of the Past, Present, and Future of Checkpoint Inhibition

This session will review the totality of emerging evidence for immune checkpoint inhibitors (ICIs) in the hepatocellular carcinoma (HCC) and biliary tract cancer (BTC) management calculus.

1.00
12/19/2022

James J. Harding, MD

Medical Oncologist
Gastrointestinal Oncology Service, Department of Medicine
Memorial Sloan Kettering Cancer Center, New York, NY

James J. Harding, MD

Medical Oncologist
Gastrointestinal Oncology Service, Department of Medicine
Memorial Sloan Kettering Cancer Center, New York, NY

R. Katie Kelley, MD

Professor of Clinical Medicine
Department of Medicine (Hematology/Oncology)
University of California, San Francisco
San Francisco, CA

R. Katie Kelley, MD

Professor of Clinical Medicine
Department of Medicine (Hematology/Oncology)
University of California, San Francisco
San Francisco, CA

Riad Salem, MD, MBA

Professor of Radiology, Medicine and Surgery
Chief, Section of Vascular and Interventional Radiology
Vice-Chair, Image-Guided Therapy, Department of Radiology
Northwestern University, Chicago, IL

Riad Salem, MD, MBA

Professor of Radiology, Medicine and Surgery
Chief, Section of Vascular and Interventional Radiology
Vice-Chair, Image-Guided Therapy, Department of Radiology
Northwestern University, Chicago, IL

On-Demand
Podcast
1.0
12/21/2022

Jennifer A. Woyach, MD


Jennifer A. Woyach, MD

Hematology-oncologist Specialist
Assistant Professor in the Division of Hematology
The Ohio State University
Columbus, OH

Sandra Kurtin, PhD, ANP-C, AOCN

Sandra Kurtin, PhD, ANP-C, AOCN

Lauren Willis, PharmD, BCOP


Lauren Willis, PharmD, BCOP

Clinical Oncology Pharmacy Specialist
Baptist Health System
Lexington, KY

Claudia A. Chiriboga, MD, MPH, FAAN

Claudia A. Chiriboga, MD, MPH, FAAN